COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

CTEPH - Chronic Thromboembolic Pulmonary Hypertension Thoughts on Di…

Mitral Foundation

R. Martin, A. Anyanwu

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Bleeding Management and Use of Anticoagulants: Panel Discussion

PERT Consortium 2021

G. Piazza, M. McDaniel, M. Huisman, D. Siegal, C. Pollack

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Pulmonary Embolism During Pregnancy

Pulmonary Embolism 2016

J. Bartholomew

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Extended Anticoagulation for VTE

Jeffrey Weitz

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

The North American Thrombosis Forum (NATF)

G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

ATS 2023 Insights

G. Heresi

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified P…

PERT Consortium 2021

M. Huisman

MERCURY-PE Trial: Does the Outpatient Treatment with Rivaroxaban Dec…

William Peacock

Medical Management of PE

NY Endovascular Summit

J. Goldfinger

PE in the Ambulatory and Hospital Settings: Scope of the Problem

PERT Consortium 2021

G. Barnes

Q&A: Thrombus Management

ARCH Advanced Revascularization Symposium

K. Rosenfield, S. Mathews, A. G. El-Shafei